AU
CAH icon

AlphaGrep UK’s Cardinal Health CAH Stock Holding History

AlphaGrep UK’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$709K Sell
2,985
-4,664
-61% -$969K 0.21% 114
2026
Q1 		$1.62M Buy
7,649
+1,291
+20% +$278K 0.47% 8
2025
Q4 		$1.31M Buy
+6,358
New +$1.2M 0.44% 12

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AlphaGrep UK's CAH Position: Q2 2026 in Review

AlphaGrep UK reduced its Cardinal Health (CAH) stake by 61% in Q2 2026, selling an estimated $969K and leaving 2,985 shares worth $709K. The position accounts for 0.21% of the portfolio, ranked #114.

AlphaGrep UK first reported a position in CAH in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.62M in Q1 2026. 1,417 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • AlphaGrep UK held 2,985 shares of Cardinal Health worth $709K as of Q2 2026.
  • AlphaGrep UK sold 4,664 Cardinal Health shares in Q2 2026, an estimated $969K.
  • Cardinal Health made up 0.21% of AlphaGrep UK's portfolio in Q2 2026, its #114 holding.
  • AlphaGrep UK first reported a position in Cardinal Health in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's Cardinal Health position peaked at $1.62M in Q1 2026.
  • 1,417 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.